Alterations of Lipid Metabolism in the Heart in Spontaneously Hypertensive Rats Precedes Left Ventricular Hypertrophy and Cardiac Dysfunction

Cells. 2022 Sep 27;11(19):3032. doi: 10.3390/cells11193032.

Abstract

Disturbances in cardiac lipid metabolism are associated with the development of cardiac hypertrophy and heart failure. Spontaneously hypertensive rats (SHRs), a genetic model of primary hypertension and pathological left ventricular (LV) hypertrophy, have high levels of diacylglycerols in cardiomyocytes early in development. However, the exact effect of lipids and pathways that are involved in their metabolism on the development of cardiac dysfunction in SHRs is unknown. Therefore, we used SHRs and Wistar Kyoto (WKY) rats at 6 and 18 weeks of age to analyze the impact of perturbations of processes that are involved in lipid synthesis and degradation in the development of LV hypertrophy in SHRs with age. Triglyceride levels were higher, whereas free fatty acid (FA) content was lower in the LV in SHRs compared with WKY rats. The expression of de novo FA synthesis proteins was lower in cardiomyocytes in SHRs compared with corresponding WKY controls. The higher expression of genes that are involved in TG synthesis in 6-week-old SHRs may explain the higher TG content in these rats. Adenosine monophosphate-activated protein kinase phosphorylation and peroxisome proliferator-activated receptor α protein content were lower in cardiomyocytes in 18-week-old SHRs, suggesting a lower rate of β-oxidation. The decreased protein content of α/β-hydrolase domain-containing 5, adipose triglyceride lipase (ATGL) activator, and increased content of G0/G1 switch protein 2, ATGL inhibitor, indicating a lower rate of lipolysis in the heart in SHRs. In conclusion, the present study showed that the development of LV hypertrophy and myocardial dysfunction in SHRs is associated with triglyceride accumulation, attributable to a lower rate of lipolysis and β-oxidation in cardiomyocytes.

Keywords: SHR rats; hypertension; hypertrophy; lipogenesis; lipolysis; myocardial metabolism; β-oxidation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Monophosphate / pharmacology
  • Animals
  • Diglycerides / metabolism
  • Fatty Acids, Nonesterified / metabolism
  • Hypertrophy, Left Ventricular* / metabolism
  • Hypertrophy, Left Ventricular* / pathology
  • Lipase / metabolism
  • Lipid Metabolism*
  • Myocytes, Cardiac / metabolism
  • PPAR alpha / metabolism
  • Protein Kinases / metabolism
  • Rats
  • Rats, Inbred SHR
  • Rats, Inbred WKY
  • Triglycerides / metabolism

Substances

  • Diglycerides
  • Fatty Acids, Nonesterified
  • PPAR alpha
  • Triglycerides
  • Adenosine Monophosphate
  • Protein Kinases
  • Lipase

Grants and funding

This research was funded by grants from the National Science Centre, Poland (no. UMO-2016/22/E/NZ4/00650 to P.D, UMO-2014/13/B/NZ4/00199 to P.D.).